Navigation Links
The International Diabetes Federation (IDF) Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes
Date:9/19/2007

AMSTERDAM, September 19 /PRNewswire/ --

- IDF Launches New Guideline for the Management of Postmeal Glucose

IDF today issued the new global guideline for diabetes care which includes the management of postmeal glucose.(1) The guideline emphasizes that people with diabetes should have their blood glucose levels closely monitored after meals in order to optimize diabetes control and reduce the risk of complications, particularly cardiovascular disease.(2) This new approach will assist clinicians and organizations in developing effective strategies for managing diabetes. The new evidence-based global guideline was unveiled at the meeting of the European Association for the Study of Diabetes (EASD) in Amsterdam.

The new guideline offers a series of recommendations identifying how diabetes care could be optimised. Topics addressed in the new guideline are postmeal hyperglycaemia, treatment strategies and regimens, self monitoring of blood glucose (SMBG), and non- pharmacologic and pharmacologic therapies.

"Diabetes is now recognized as one of the largest epidemics humanity has ever faced and a leading cause of death. It accounts for 3.8 million deaths per year, many of which are related to cardiovascular disease. This new advancement underscores the importance for people with diabetes and their healthcare providers to adopt all possible ways to better manage the disease," said Professor Stephen Colagiuri, Chair of the IDF Task Force on Clinical Guidelines.

Until recently, a key recommendation for good diabetes management was to lower fasting or premeal blood glucose levels; however, recent studies suggest a link between postmeal glucose control and improved outcomes in people with diabetes. Existing global guidelines do not include the management of postmeal glucose.

In people with normal glucose tolerance, blood glucose levels are automatically monitored and controlled by the body. After eating, the body releases enough insulin to keep the plasma glucose within a normal range that rarely rises above 7.8 mmol/l (140 mg/dl) and usually returns to premeal levels within two to three hours.

In people with impaired glucose tolerance or diabetes, their body has little or no automatic control of blood glucose levels. After eating, they often experience extended periods of elevated blood glucose levels. This is due to a number of factors, including insufficient insulin secretion, decreased sensitivity to insulin action, inability to suppress glucose output from the liver and deficiencies in other hormones related to digestion.

The new IDF Guideline recommends that people with diabetes try to keep postmeal blood glucose levels to less than 7.8 mmol/l (140 mg/dl) two hours following a meal, a time frame which conforms to guidelines published by most of the leading diabetes and medical organizations.

IDF advises SMBG because it is the most practical method for measuring postmeal glucose and it allows people with diabetes to obtain "real-time" information about their glucose levels. This information enables people with diabetes and their healthcare providers to make timely adjustments in their treatment regimens to achieve and maintain their blood glucose levels within target.

"IDF recommends that people with diabetes include physical activity, healthy eating and weight control in their daily regimen," said Professor Antonio Ceriello, Chair of the Guideline Writing Group. "These remain the cornerstone of effective diabetes management and not only reduce postmeal glucose levels, but also improve blood pressure and cholesterol levels". The guideline also includes information on a number of medications which specifically target postmeal glucose levels.

Note to Editors

The International Diabetes Federation (IDF) is an umbrella organization of over 200 member associations in more than 160 countries, advocating for the 250 million people with diabetes, their families, and their healthcare providers. The mission of IDF is to promote diabetes care, prevention and a cure worldwide. IDF is an NGO in official relations with the World Health Organization and associated with the United Nations Department of Public Information. Additional information about IDF is available at http://www.idf.org.

References:

1 Guideline for Management of Postmeal Glucose, International Diabetes Federation, 2007

2 Ceriello A, Postprandial Hyperglycemia and Diabetes Complications: Is it Time to Treat? Diabetes 2005; 54(1):1-7


'/>"/>
SOURCE International Diabetes Federation (IDF)
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Olympics of biotechnology has international flavor
2. Traffic data firm navigates international business
3. Catalyst International profit exceeds expectations
4. Lack of broadband hamstrings international videoconferencing
5. 30 days to success: Three simple steps to create your own international startup
6. TEKLYNX International announces new RFID software
7. Ruling enforces international trademark electronic filing requirements
8. Eleftheriou to lead Catalyst International
9. Internet trademark war goes international
10. International eyes drawn to Madisons games research
11. Plexus and SRI International team up to offer medical product development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... NY (PRWEB) , ... December 01, 2016 , ... The ... is expanding to three days and will take place on February 1-3, 2017 at ... and Dr James Gulley (NCI), the program provides a unique 360-degree approach, which addresses ...
(Date:12/2/2016)... , ... December 02, 2016 ... ... a consortium of pharmaceutical and biotechnology companies dedicated to collaboratively developing improved ... interested in supplying a vendor-supported, portable online UHPLC, with robust, probe-based sampling. ...
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected ... of 7.3% during the forecast period of 2016 to 2021 dominated ... accounted for the largest share of immunohistochemistry (IHC) market, by end ... , , ... market spread across 225 pages, profiling 10 companies and supported with ...
(Date:11/30/2016)... , Nov. 30, 2016  GenomOncology today announced the ... President of Medical Affairs.  Dr. Coleman will ... the company,s proprietary knowledge-enabled platform. The GenomOncology software suite empowers ... genetic sequencing data and clinical decision support, from quality control ... , ...
Breaking Biology Technology:
(Date:6/27/2016)... , June 27, 2016 Research and Markets ... America 2016-2020" report to their offering. ... North America to grow at a CAGR of 12.28% ... prepared based on an in-depth market analysis with inputs from industry ... over the coming years. The report also includes a discussion of ...
(Date:6/20/2016)... June 20, 2016 Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring ... involved, it has secured the final acceptance by ... for Managed Access Systems (MAS) installed. Furthermore, Securus ... to be installed by October, 2016. MAS distinguishes ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
Breaking Biology News(10 mins):